EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular Vesicle Treatment Alleviates Neurodevelopmental and Neurodegenerative Pathology in Cortical Spheroid Model of Down Syndrome

Natalie Baker Campbell, Yesha Patel, Tara L Moore, Maria Medalla, Ella Zeldich

International Journal of Molecular Sciences · 09.02.2023 · 24 (4) · 3477

DOI: 10.3390/ijms24043477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.02.2023. Verfasst von Natalie Baker Campbell und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy & Neurobiology, Boston University Chobanian & Avedesian School of Medicine, Boston University, Boston, MA 02118, USA. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Extracellular Vesicles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Down syndrome (DS), or trisomy 21, is manifested in a variety of anatomical and cellular abnormalities resulting in intellectual deficits and early onset of Alzheimer’s disease (AD) with no effective treatments available to alleviate the pathologies associated with the disorder. The therapeutic potential of extracellular vesicles (EVs) has emerged recently in relation to various neurological conditions. We have previously demonstrated the therapeutic efficacy of mesenchymal stromal cell-derived EVs (MSC-EVs) in cellular and functional recovery in a rhesus monkey model of cortical injury. In the current study, we evaluated the therapeutic effect of MSC-EVs in a cortical spheroid (CS) model of DS generated from patient-derived induced pluripotent stem cells (iPSCs). Compared to euploid controls, trisomic CS display smaller size, deficient neurogenesis, and AD-related pathological features, such as enhanced cell death and depositions of amyloid beta (Aβ) and hyperphosphorylated tau (p-tau). EV-treated trisomic CS demonstrated preserved size, partial rescue in the production of neurons, significantly decreased levels of Aβ and p-tau, and a reduction in the extent of cell death as compared to the untreated trisomic CS. Together, these results show the efficacy of EVs in mitigating DS and AD-related cellular phenotypes and pathological depositions in human CS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeAlzheimer DiseaseExtracellular VesiclesHumansAmyloid beta-PeptidesNeurons

Stichwörter der Autor:innen

Alzheimer’s diseaseDown syndromebrain organoidsextracellular vesiclesmesenchymal stem cellstrisomy

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Anatomy & Neurobiology, Boston University Chobanian & Avedesian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Commonwealth Honors College, University of Massachusetts Amherst, Amherst, MA 01003, USA.
  • Center for Systems Neuroscience, Boston University, Boston, MA 02115, USA.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

Campbell, N. B., Patel, Y., Moore, T. L., Medalla, M., & Zeldich, E. (2023). Extracellular Vesicle Treatment Alleviates Neurodevelopmental and Neurodegenerative Pathology in Cortical Spheroid Model of Down Syndrome. International Journal of Molecular Sciences, 24(4), 3477. https://doi.org/10.3390/ijms24043477

Vancouver

Campbell NB, Patel Y, Moore TL, Medalla M, Zeldich E. Extracellular Vesicle Treatment Alleviates Neurodevelopmental and Neurodegenerative Pathology in Cortical Spheroid Model of Down Syndrome. International Journal of Molecular Sciences. 2023;24(4):3477. doi:10.3390/ijms24043477

BibTeX
@article{Campbell2023,
  author = {Campbell, Natalie Baker and Patel, Yesha and Moore, Tara L and Medalla, Maria and Zeldich, Ella},
  title = {Extracellular Vesicle Treatment Alleviates Neurodevelopmental and Neurodegenerative Pathology in Cortical Spheroid Model of Down Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3477},
  doi = {10.3390/ijms24043477}
}
Kostenlos starten →